 | Up a level |
Till, Kathleen J 
ORCID: 0000-0002-3172-5771, Allen, John C, Talab, Fatima, Lin, Ke, Allsup, David, Cawkwell, Lynn, Bentley, Alison, Ringshausen, Ingo, Duckworth, Andrew D, Pettitt, Andrew R et al (show 2 more authors)
(2017)
Lck is a relevant target in chronic lymphocytic leukaemia cells whose expression variance is unrelated to disease outcome.
SCIENTIFIC REPORTS, 7 (1).
16784-.
Kennedy, Paul T ORCID: 0000-0001-5668-9132, Saulters, Emma L ORCID: 0009-0000-0273-0873, Duckworth, Andrew D, Lim, Yeong Jer, Woolley, John F, Slupsky, Joseph R ORCID: 0000-0002-7410-9004, Cragg, Mark S ORCID: 0000-0003-2077-089X, Ward, Frank J and Dahal, Lekh N ORCID: 0000-0001-8390-6593
(2024)
Soluble CTLA-4 attenuates T cell activation and modulates anti-tumor immunity.
Molecular therapy : the journal of the American Society of Gene Therapy, 32 (2).
pp. 457-468.